$9.80
0.000.00%
Pre-Market: Dec 20, 4:37 PM EDT
Comments
Loading...
Amicus Therapeutics (FOLD) Forecast
NewsEarningsAmicus Therapeutics (FOLD) OptionsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestAmicus Therapeutics (NASDAQ:FOLD) Stock Quotes, Forecast and News Summary
Amicus Therapeutics Stock (NASDAQ: FOLD) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Amicus Therapeutics (FOLD) stock?
You can purchase shares of Amicus Therapeutics (NASDAQ:FOLD) through any online brokerage.
Who are Amicus Therapeutics (FOLD) competitors?
Other companies in Amicus Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for Amicus Therapeutics (FOLD) stock?
Amicus Therapeutics has a consensus price target of $15.92.
What is the current price for Amicus Therapeutics (FOLD)?
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $9.8 last updated December 20, 2024 at 4:37 PM EST.
Does Amicus Therapeutics (FOLD) pay a dividend?
There are no upcoming dividends for Amicus Therapeutics.
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics’s Q4 earnings are confirmed for Wednesday, February 26, 2025.
Is Amicus Therapeutics (FOLD) going to split?
There is no upcoming split for Amicus Therapeutics.
What sector and industry does Amicus Therapeutics (FOLD) operate in?
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.